Irazu Oncology
- Biotech or pharma, therapeutic R&D
Irazu Oncology, LLC is a pioneering preclinical biotech company founded in 2022 in Baltimore, Maryland, focused on developing cutting-edge cancer immunotherapy leveraging Outer Membrane Vesicles (OMVs) to target colorectal cancer (CRC) and other solid tumors. With $4.3M in seed funding, Irazu combines scientific innovation with experienced leadership to address critical unmet needs in oncology.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}